Glycobiology Disease Model Construction Service
Committed to Excellence in Glycobiology Disease Model Construction
In recent years, more and more studies have shown that glycosylation is closely related to the occurrence and development of various diseases. Abnormal glycosylation may lead to protein dysfunction, which in turn affects cell-to-cell recognition, signal transduction, immune response, and other life activities, thereby causing or exacerbating a variety of diseases.
At CD BioGlyco, we rely on our rich experience and professional technical team to provide clients with high-quality Glycobiology Disease Model Development Services, including Custom In Vivo Glycobiology Disease Model Service, In Vivo Glycobiology Disease Model Screening Service, and In Vitro Glycobiology Disease Model Screening Service.

We provide comprehensive glycobiology disease model construction service to meet the needs of scientific researchers and pharmaceutical developers for glycosylation-related disease models. Our services cover but are not limited to the following disease models.
We construct reliable animal models to study the connection between glycosylation, autoimmunity, and inflammation. Aberrant glycosylation is often associated with autoimmune and inflammatory conditions, and the model is developed to accelerate the detection and development of drugs targeting these diseases.
- Rheumatoid Arthritis Model Construction Service
- Inflammatory Bowel Disease Model Construction Service
- Systemic Lupus Erythematosus Model Construction Service
- Tn Syndrome Model Construction Service
- Diabetes Mellitus Model Construction Service
We construct high-standard models to study the impact of glycosylation in the pathogenesis of gastrointestinal diseases. We reveal underlying mechanisms through these models.
- Colonic Propulsive Motility Model Construction Service
- Dextran Sodium Sulfate (DSS) -Induced Colitis Model Construction Service
- Gastrointestinal Transit Model Construction Service
- Irritable Bowel Syndrome (IBS) Model and Acetylcholine Writhing Model Construction Service
In cardiovascular diseases, abnormal glycosylation may be involved in processes such as proliferation, migration, inflammatory response, and thrombosis of blood vessel wall cells. Our cardiovascular model construction service aims to construct cardiovascular disease models that simulate these glycosylation abnormalities to study their role in cardiovascular disease.
- Anti-Thrombotic Model Construction Service
- Hypertension Model Construction Service
In kidney disease, abnormal glycosylation may affect the function of the glomerular filtration barrier, tubular reabsorption function, and renal inflammatory response. We establish kidney disease models by studying the glycosylation process and the pathophysiological changes it causes, which is crucial for studying effective treatments and related drug screening.
- Cisplatin-Induced Acute Kidney Injury Model Construction Service
- LPS-Induced Acute Kidney Injury Model Construction Service
- Pan-Induced Renal Podocyte Injury Model Construction Service
- Unilateral Renal Ischemia & Reperfusion Model Construction Service
- Bilateral Renal Ischemia & Reperfusion Model Construction Service
- IgA Nephropathy-Induced Model Construction Service
In fibrotic diseases, abnormal glycosylation may promote excessive proliferation and deposition of fibrotic tissue. Our fibrosis disease model construction service builds fibrosis disease models that simulate these glycosylation abnormalities to study their role in the fibrosis process.
- Carbon Tetrachloride (CCL4)-Induced Fibrosis Model Construction Service
- Thioacetamide (TAA)-Induced Fibrosis Model Construction Service
- High-Fat & Cholesterol Diet (HFCD)-Induced Fibrosis Model Construction Service
- STZ-Induced Pulmonary Fibrosis Construction Service
- N-Nitrosodiethylamine (DEN)-Induced Liver Fibrosis Model Construction Service
We also provide other model construction services and customized services for glycosylation-related diseases. No matter which disease you are concerned about, we are willing to provide you with professional solutions.
- Oncology Model Construction Service
- Aging Model Construction Service
- Pain Model Construction Service
- Liver Disease Model Construction Service
- Acute Lung Injury Model Construction Service
- LPS-induced Sepsis Model Construction Service
Our glycobiology disease model construction services process consists of multiple stages. First, we use advanced glycomics technology to analyze the composition, structure, and functional changes of glycans in disease states. Next, methods such as chemistry, biology, and synthetic biology are used to precisely synthesize or modify these glycans to simulate disease states. Finally, these glycans are integrated into cells or animal models to create disease models that simulate the disease process.
- Disease analysis
First, we collect disease samples and use glycomic technologies such as mass spectrometry and nuclear magnetic resonance to conduct a comprehensive analysis of disease-related glycans. We identify relevant glycan structures associated with specific diseases. We do this using a range of advanced glycobiology tools and techniques, such as mass spectrometry (MS) and nuclear magnetic resonance (NMR).
- Glycan synthesis
Based on the analysis results of disease glycans, we use chemical synthesis, enzymatic synthesis, and other methods to accurately synthesize or transform these glycan chains. This process requires highly precise techniques and extensive experience to ensure that the structure and function of the glycan chains are consistent with the disease state.
- Disease model construction
We integrate synthetic or modified glycans into cells or animal models to construct disease models that can simulate the disease process. To construct these models, we utilize state-of-the-art genetic engineering techniques to embed relevant glycan structures into in vitro or in vivo models. This involves altering the genes of bacteria, animal cells, or animals to produce the desired glycans. This process requires comprehensive consideration of the interaction between glycan chains and cells and tissues, as well as the complexity of the disease process.
- Model validation and optimization
We perform comprehensive bioassays to test whether the model correctly simulates the disease of interest. This includes studying changes in glycan structure in diseased and healthy states and the impact on cell function. Based on the experimental results, the model is optimized and improved to improve its predictive ability and application value.
Publication Data
Technology: Development of human stem cell-based cell culture models
Journal: Molecular & Cellular Proteomics
IF: 7.0
Published: 2016
Results: The researchers created human stem cell-based cell culture models that gradually reduced levels of N-glycosylation. The team succeeded in generating induced pluripotent stem cells (iPSCs) from the fibroblasts of a patient suffering from the genetic disorder phosphomannomutase 2 congenital disorder of glycosylation (PMM2-CDG), which they labeled as PMM2-iPSCs. The authors found that the PMM2-iPSC-C3 model exhibited the usual N-glycosylation pattern found in hPSC with high-mannose-type N-glycans being the dominant species.
Fig.1 Scheme for N-glycosylation in PMM2-IPSC models. (Thiesler, et al., 2016)
Applications
- Development of disease biomarkers: Glycobiology disease model construction services play an important role in the identification and development of disease biomarkers. These disease-specific indicators reveal intrinsic patterns of glycosylation disruption associated with various diseases, thereby providing important insights into disease processes at the molecular level.
- Development of drugs: Researchers target these carbohydrate molecules or their interactions by recreating disease conditions and studying the role of glycans in disease progression, potentially developing innovative drugs.
- Study of cell-cell interactions: Glycan chains play an important role in cell-cell interactions. The researchers use glycobiological disease models to simulate the glycan recognition and binding process between cells and reveal the molecular mechanism of cell-cell interactions.
- Research on disease pathogenesis: Glycobiological disease models can be used to study the role of glycan and glycome changes in disease progression, potentially providing knowledge about the key molecular and cellular mechanisms involved.
At CD BioGlyco, our glycobiology disease model construction service provides scientific researchers and pharmaceutical developers with powerful research tools. We have rich technical experience and a professional team to provide clients with high-quality disease models. Please feel free to contact us if you are interested in our glycobiology disease model construction service.
Reference
- Thiesler, C.T.; et al. Glycomic characterization of induced pluripotent stem cells derived from a patient suffering from phosphomannomutase 2 congenital disorder of glycosylation (PMM2-CDG). Molecular & Cellular Proteomics. 2016, 15(4): 1435-1452.
Quick Links
Resources
- Fatty Acid Analysis
- Omega-3 Fatty Acid Analysis
- Omega-6 Fatty Acid Analysis
- Esterified Fatty Acid Analysis
- Saturated Fatty Acid Analysis
- Straight-chain Fatty Acid Analysis
- Volatile Fatty Acid Analysis
- Cis/Trans Fatty Acid Analysis
- Whole-Cell Fatty Acid Analysis
- Free Fatty Acid Analysis
- Total Fatty Acid Analysis
- Long-chain Fatty Acid Analysis
- Short-chain Fatty Acid Analysis
- Glycosylation Inhibitor Development
- Metabolic Interconversion Inhibitor Development
- N-Glycosylation Inhibitor Development
- O-Glycosylation Inhibitor Development
- O-GalNAc Inhibitor Development
- Core 1 Inhibitor Development
- Core 2 Inhibitor Development
- Core 3 Inhibitor Development
- Core 4 Inhibitor Development
- Sialyl-Tn Antigen Inhibitor Development
- Sialyl-T Antigen Inhibitor Development
- SLex Antigen Inhibitor Development
- Blocking O-Glycan-Protein Interaction Inhibitor Development
- Capping Modification Inhibitor Development
- Postsynthetic Glycan Modification Inhibitor Development
- GAG Inhibitor Development
- GSL Inhibitor Development
- GPI Anchor Inhibitor Development
- O-GlcNAc Inhibitor Development
- Lipidomics Analysis Services
- Carbohydrate Separation, Purification and Analysis
- Carbohydrate Metabolism Analysis
- Monosaccharide Analysis Service
- Mannitol Analysis Service
- Mannose Analysis Service
- Fructose Analysis Service
- Xylose Analysis Service
- Glucose Analysis Service
- Sorbitol Analysis Service
- Galactose Analysis Service
- Fucose Analysis Service
- Arabinose Analysis Service
- Ribose Analysis Service
- Rhamnose Analysis Service
- Galacturonic Acid Analysis Service
- Glucuronic Acid Analysis Service
- Galactosamine Analysis Service
- Mannuronic Acid Analysis Service
- Guluronic Acid Analysis Service
- Mannosamine Analysis Service
- Glucosamine Analysis Service
- Muramic Acid Analysis Service
- N-Acetylglucosamine Analysis Service
- Tagatose Analysis Service
- Talose Analysis Service
- Psicose Analysis Service
- Sorbose Analysis Service
- Disaccharide Analysis Service
- Maltose Analysis Service
- Isomaltose Analysis Service
- Lactose Analysis Service
- Sucrose Analysis Service
- Trehalose Analysis Service
- Melibiose Analysis Service
- Turanose Analysis Service
- Lactulose Analysis Service
- Maltitol Analysis Service
- Lactitol Analysis Service
- Epilactose Analysis Service
- Cellobiose Analysis Service
- Allolactose Analysis Service
- Maltotriose Analysis Service
- Isomaltulose Analysis Service
- Oligosaccharide Analysis Service
- Raffinose Analysis Service
- Stachyose Analysis Service
- Mannan Oligosaccharides Analysis Service
- Xylooligosaccharide Analysis Service
- Fructooligosaccharide Analysis Service
- Galactooligosaccharide Analysis Service
- Chitooligosaccharide Analysis Service
- Arabinoxylooligosaccharide Analysis Service
- Pectic Oligosaccharide Analysis Service
- Maltooligosaccharide Analysis Service
- Isomaltooligosaccharide Analysis Service
- Polysaccharide Analysis Service
- Sea Cucumber Polysaccharide Analysis Service
- Lycium barbarum Polysaccharide Analysis Service
- Polygonatum Polysaccharide Analysis Service
- Glycogen Analysis Service
- Glucomannan Analysis Service
- Chitin/Chitosan Analysis Service
- Glucan Analysis Service
- Galactan Analysis Service
- Xylan Analysis Service
- Mannan Analysis Service
- Arabinan Analysis Service
- Rhamnan Analysis Service
- Fucoidan Analysis Service
- Galactomannan Analysis Service
- Glycosaminoglycan Analysis Service
- Monosaccharide Analysis Service
- Custom Glycosylation Service
- Sialic Acid Analysis Service
- Strategies for Sialic Acid Analysis
- Aberrant Sialylation in Cancers
- Sialic Acid Analysis in Pancreatic Cancer
- Sialic Acid Analysis in Laryngeal Cancer
- Sialic Acid Analysis in Oral Cancer
- Sialic Acid Analysis in Cholangiocarcinoma
- Sialic Acid Analysis in Cervical Cancer
- Sialic Acid Analysis in Leukemia
- Sialic Acid Analysis in Colorectal Cancer
- Sialic Acid Analysis in Lung Cancer
- Sialic Acid Analysis in Breast Cancer
- Sialic Acid Analysis in Endometrial Cancer
- Sialic Acid Analysis in Stomach Cancer
- Sialic Acid Analysis in Thyroid Cancer
- Sialic Acid Analysis in Malignant Melanoma
- Sialic Acid Analysis in Prostate Cancer
- Sialic Acid Analysis in Ovarian Cancer
- Custom Sialyl Tumor Antigen Production Service
- High-Throughput Glycan Screening Service
- HTS of Important Glycans
- HTS of Glycan Derivatives
- HTS for Glycan-Binding Proteins
- HTS for Compounds That Alter Muscle Cell Glycosylation
- HT Glycan Screening for Antibodies
- HT Glycan Screening for Glycoengineered Cell Line
- HTS for Human Galactokinase Inhibitors
- HTS for Inhibitors of Sialyl- and Fucosyltransferases
- HT Automated Micro-Permethylation for Glycan Structure Analysis
- Strategies for HT Glycan Screening
- HT Glycan Screening Using Microchip-Based Assay
- HT Glycan Screening Using Miniature Pig Kidney N-Glycan-Immobilized Beads
- HT Glycan Screening Using An Automated LC-MS-Based Solution
- HT Glycan Screening Using Mass Spectrometry
- HT Glycan Screening Using UHPLC-FLD
- HT Glycan Screening Using 19F-Labeled Probes
- HT Glycan Screening Using Hydrophilic Interaction Chromatography
- HT Glycan Screening Using MALDI-TOF-MS
- HT Glycan Screening Using CE-MS
- HT Glycan Screening Using HPLC-Based Analysis
- HT Glycan Screening Using ESI-MSn
- HT Glycan Screening Using a DNA Sequencer
- HT Glycan Screening Using Glycan Microarrays
- HT Glycan Screening Using a 96-Well Plate Platform
- Characterization of Glycosylation in Drugs
- Glycobiology of Human Milk
- Anti-glycan Antibody Development
- Lectin Production Service
- Pharmaceutical and Biological Analysis Service
- Pharmaceutical Analysis Service
- Oral Rehydration Salt Analysis Service
- Pentoxifylline and Glucose Injection Analysis Service
- Xylitol Analysis Service
- Ulinastatin Analysis Service
- Deslanoside Analysis Service
- Glycerol Fructose and Sodium Chloride Injection Analysis Service
- Josamycin Propionate Analysis Service
- Dextran Analysis Service
- Iron Dextran Analysis Service
- Capecitabine Analysis Service
- Metildigoxin Analysis Service
- Metronidazole and Glucose Injection Analysis Service
- Gadobenate Dimeglumine Injection Analysis Service
- Voglibose Analysis Service
- Inosine and Glucose Injection Analysis Service
- Heparin Calcium Analysis Service
- Heparin Sodium Analysis Service
- Acarbose Analysis Service
- Amikacin Analysis Service
- Aciclovir and Glucose Injection Analysis Service
- Streptomycin Injection Analysis Service
- Erythromycin Lactobionate Analysis Service
- Saccharated Pepsin Analysis Service
- Compound Sodium Lactate and Glucose Injection Analysis Service
- Tylosin Analysis Service
- Compound Calcium Gluconate Oral Solution Analysis Service
- Cytarabine Hydrochloride for Injection Analysis Service
- Oxystarch Analysis Service
- Glucosamine Indometacin Enteric Capsule Analysis Service
- Glucose and Sodium Chloride Injection Analysis Service
- Ferrous GIuconate Analysis Service
- Calcium Gluconate Analysis Service
- Calcium Gluconate and Sodium Chloride Injection Analysis Service
- Zinc Gluconate Analysis Service
- Sodium Stibogluconate Analysis Service
- Chlorhexidine Gluconate Analysis Service
- Sodium Stibogluconate Injection Analysis Service
- Kanamycin Sulfate Analysis Service
- Gentamicin Sulfate Analysis Service
- Isepamicin Sulfate Analysis Service
- Amikacin Sulfate Analysis Service
- Chondroitin Sulfate Sodium Analysis Service
- Etimicin Sulfate Analysis Service
- Ribostamycin Sulfate Analysis Service
- Streptomycin Sulfate Analysis Service
- Neomycin Sulfate Analysis Service
- Sucralfate Analysis Service
- Potassium Chloride and Glucose Injection Analysis Service
- Anticoagulant Citrate Dextrose Analysis Service
- Aurothioglucose Analysis Service
- Calcium Gluceptate Analysis Service
- Calcium Lactobionate Analysis
- Calcium Levulinate Analysis
- Oxidized Cellulose Analysis
- Oxidized Regenerated Cellulose Analysis
- Cellulose Sodium Phosphate Analysis
- Chlorpromazine Hydrochloride Syrup Analysis
- Clofibrate Capsule Analysis
- Copper Gluconate Analysis
- Cytarabine Analysis
- Dextrose Analysis
- Diatrizoate Meglumine Analysis
- Digitoxin Analysis
- Digoxin Analysis
- Dihydrostreptomycin Sulfate Analysis
- Dirithromycin Analysis
- Enoxaparin Sodium Analysis
- Erythromycin Analysis
- Erythromycin Estolate Analysis
- Erythromycin Ethylsuccinate Analysis
- Sterile Erythromycin Gluceptate Analysis
- Ferrous Sulfate Syrup Analysis
- Fludeoxyglucose F 18 Injection Analysis
- Beta Glucan Analysis
- Gentamicin and Prednisolone Acetate Ophthalmic Ointment Analysis
- Gluconolactone Analysis
- Heparin Lock Flush Solution Analysis
- Anticoagulant Heparin Solution Analysis
- Hyaluronidase Injection Analysis
- Iodipamide Meglumine Injection Analysis
- Iron Sorbitex Injection Analysis
- Iron Sucrose Injection Analysis
- Magnesium Gluconate Analysis
- Manganese Gluconate Analysis
- Meglumine Analysis
- Natamycin Analysis
- Quinidine Gluconate Analysis
- Sisomicin Sulfate Analysis
- Sodium Gluconate Analysis
- Biological Evaluation
- Typhoid Vaccine Evaluation
- RNA-Cell Binding Interaction Analysis Services
- Group A Meningococcal Polysaccharide Vaccine Evaluation
- Off-Target Activity Assessment Service
- 23-Valent Pneumococcal Polysaccharide Vaccine Evaluation
- Conjugate Potency Assay Service
- H. influenzae Type b Conjugate Vaccine Evaluation
- ADME Profiling Service
- Poliomyelitis Vaccine in Dragee Candy Evaluation
- Human Hepatitis B Immunoglobulin Evaluation
- Human Rabies Immunoglobulin Evaluation
- Human Tetanus Immunoglobulin Evaluation
- Human Immunoglobulin Evaluation
- Anti-human T Lymphocyte Rabbit Immunoglobulin Evaluation
- Human Fibrinogen Evaluation
- Human Thrombin Evaluation
- Conbercept Ophthalmic Injection Evaluation
- BCG-PPD Evaluation
- BR-PPD Evaluation
- Pharmaceutical Excipient Analysis
- Ethylcellulose Analysis Service
- Sucralose Analysis
- Wheat Starch Analysis
- Potato Starch Analysis
- Tapioca Starch Analysis
- Maize Starch Analysis
- Compressible Sugar Analysis
- Soluble Starch Analysis
- Methylcellulose Analysis
- Guar Gum Analysis
- Tragacanth Analysis
- Croscarmellose Sodium Analysis
- Cellacefate Analysis
- Maltodextrin Analysis
- Low-substituted Hydroxypropyl Cellulose Analysis
- Alpha Cyclodextrin Analysis
- Beta Cyclodextrin Analysis
- Gamma Cyclodextrin Analysis
- Arabino Galactan Analysis
- Acacia Analysis
- Pectin Analysis
- Powdered Cellulose Analysis
- Alginic Acid Analysis
- Sodium Alginate Analysis
- Pregelatinized Hydroxypropyl Starch Analysis
- Pregelatinized Starch Analysis
- Xanthan Gum Analysis
- Steviol Glycoside Analysis
- Hydroxyethyl Cellulose Analysis
- Hypromellose Analysis
- Hydroxypropyl Cellulose Analysis
- Hydroxypropyl Betadex Analysis
- Vacant HydroxypropyI Starch Capsule Analysis
- Dextrate Analysis
- Agar Analysis
- Calcium Saccharate Analysis
- Caramel Analysis
- Pullulan Analysis
- Microcrystalline Cellulose Analysis
- Carboxymethylcellulose Calcium Analysis
- Carboxymethylcellulose Sodium Analysis
- Sodium Starch Glycolate Analysis
- Polydextrose Analysis
- Sucrose Octaacetate Analysis
- Sugar Sphere Analysis
- Sucrose Stearate Analysis
- Pea Starch Analysis
- Cellulose Acetate Analysis
- Hypromellose Acetate Succinate Analysis
- Dextrin Analysis
- Sodium Starch Phosphate Analysis
- Gellan Analysis
- Hyaluronan Analysis
- Pharmaceutical Analysis Service
- Carbohydrate-based Biodegradable Material Development
- Monosaccharide-based Biodegradable Material Development
- Disaccharide-based Biodegradable Material Development
- Oligosaccharide-based Biodegradable Material Development
- Polysaccharide-based Biodegradable Material Development
- Cellulose-based Biodegradable Material Development
- Starch-based Biodegradable Material Development
- Chitosan-based Biodegradable Material Development
- Dextran-based Biodegradable Material Development
- Hyaluronic Acid-based Biodegradable Material Development
- Other Polysaccharide-based Biodegradable Material Development
- Modification of Biodegradable Polysaccharide
- Characterization of Polysaccharide-based Biodegradable Material
- Applications of Polysaccharide-based Biodegradable Material
- Glycobiology Disease Model Development Service
- Techniques for In Vivo Glycobiology Disease Model Development
- Gene Editing-based In Vivo Glycobiology Disease Model Development Service
- Transgenic-based In Vivo Glycobiology Disease Model Development Service
- Embryo Implantation and Cultivation-based In Vivo Glycobiology Disease Model Development Service
- Selective Breeding-based In Vivo Glycobiology Disease Model Development Service
- Gene Expression-based In Vivo Glycobiology Disease Model Development Service
- Glycobiology Disease Model Construction Service
- Custom In Vivo Glycobiology Disease Model Service
- In Vivo Glycobiology Disease Model Screening Service
- In Vitro Glycobiology Disease Model Screening Service
- HeLa Cells-based In Vivo Screening Service
- 3T3-L1 Cells-based In Vitro Screening Service
- Muscle Cells-based In Vitro Screening Service
- Hepatocyte-based In Vitro Screening Service
- Insulin Target Cells-based In Vitro Screening Service
- Intestinal Cells-based In Vitro Screening Service
- THP-1 Monocyte-based In Vitro Screening Service
- Vero Cells-based In Vitro Screening Service
- Techniques for In Vivo Glycobiology Disease Model Development
- Fatty Acid Analysis




